Author:
Boyiadzis Michael,Bishop Michael R.,Abonour Rafat,Anderson Kenneth C.,Ansell Stephen M.,Avigan David,Barbarotta Lisa,Barrett Austin John,Van Besien Koen,Bergsagel P. Leif,Borrello Ivan,Brody Joshua,Brufsky Jill,Cairo Mitchell,Chari Ajai,Cohen Adam,Cortes Jorge,Forman Stephen J.,Friedberg Jonathan W.,Fuchs Ephraim J.,Gore Steven D.,Jagannath Sundar,Kahl Brad S.,Kline Justin,Kochenderfer James N.,Kwak Larry W.,Levy Ronald,de Lima Marcos,Litzow Mark R.,Mahindra Anuj,Miller Jeffrey,Munshi Nikhil C.,Orlowski Robert Z.,Pagel John M.,Porter David L.,Russell Stephen J.,Schwartz Karl,Shipp Margaret A.,Siegel David,Stone Richard M.,Tallman Martin S.,Timmerman John M.,Van Rhee Frits,Waller Edmund K.,Welsh Ann,Werner Michael,Wiernik Peter H.,Dhodapkar Madhav V.
Subject
Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy
Reference221 articles.
1. Ansell SM, Lesokhin AM, Borrello I, Halwani A, Scott EC, Gutierrez M, et al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. N Engl J Med. 2015;372(4):311–9. doi: 10.1056/NEJMoa1411087 .
2. Kaufman HL, Kirkwood JM, Hodi FS, Agarwala S, Amatruda T, Bines SD, et al. The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma. Nat Rev Clin Oncol. 2013;10(10):588–98. doi: 10.1038/nrclinonc.2013.153 .
3. Institute of Medicine Committee on Standards for Developing Trustworthy Clinical Practice G. In: Graham R, Mancher M, Miller Wolman D, Greenfield S, Steinberg E, editors. Clinical Practice Guidelines We Can Trust. Washington (DC): National Academies Press (US) Copyright 2011 by the National Academy of Sciences. All rights reserved.; 2011
4. Society for Immunotherapy of Cancer Cancer Immunotherapy Guidelines. https://www.sitcancer.org/resources/cancer-immunotherapy-guidelines .
5. Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2010;364(11):1046–60.